EAACI-Allergopharma Research Award
Allergopharma Award, EAACI Executive Committee
With the EAACI-Allergopharma Research Award, we want to acknowledge talented young researchers and motivate them to drive innovation in the field of allergy research.
The award was established in 2000, on the initiative of Allergopharma, in collaboration with the European Academy of Allergy and Clinical Immunology. It is intended that the award should recognize scientific achievement of young scientists working in the field of allergy and encourage their engagement in further research.
Therefore, the award is open to EAACI Junior Members who have conducted their research in a European center. More information on EAACI Junior Members you will find by clicking here. (“EAACI Junior Membership shall be available to all those who are aged 35 years or less at the time of renewal of their subscription.”)
The award is valued at EUR 10,000 and will be granted to the institution or research organization the awardee primarily conducts the research for. The awardee will be presented with the EAACI Allergopharma Research Award during the Opening Ceremony of the EAACI annual congress. Registration to the congress will be supported by the grant.
For more information about the application procedure and general guidelines please visit the EAACI website.
Previous winners of the Allergopharma Award:
2023
Marine-Alexia Lefevre, PhD
Centre International de Recherche en Infectiologie (CIRI), Lyon, France
Project: Contact dermatitis: from biomarker discovery to the development of new molecular diagnostic approaches
2022
Janice Layhadi, PhD
Imperial College London, London, Great Britain
Project: Precision Immunology And Biomarkers Of Allergy And Immunotherapy
2021
Maria Pino-Yanes, PhD
Universidad de La Laguna San Cristóbal, San Cristóbal De La Laguna/Spain
Project: Uncovering The Genetic Component Of Asthma And Asthma-Related Phenotypes In Populations With African Admixture
2020
Rodrigo Jiménez Saiz, PhD
National Centre for Biotechnology (CNB)-CSIC, Madrid/Spain
Project: The IgE Memory Reservoir In Food Allergy
2019
Flore Amat, MD, PhD
Epidémiologie des Maladies Allergiques et Respiratoires, France
Project: Risk factors for asthma at school age in children with early-onset atopic dermatitis
2018
Brecht Steelant, PhD, Postdoctoral Researcher
KU Leuven, Leuven, Belgium
Project: Role of the epithelial barrier in the pathophysiology of allergic rhinitis
2017
Kristina Johansson, PhD
Krefting Research Centre, University of Gothenburg, Sweden
Project: MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation (J Allergy Clin Immunol. 2017 Mar; 139(3): 1007-1016)
2016
Irisz Karolina Levai, MD
University of Kent, Great Britain
Project: Continuous laryngoscopy during exercise and assessment of parasympathetic activity in patients with exercise-induced laryngeal obstruction (EILO)
2015
Alexander Eggel, PhD
University Hospital Bern, Switzerland
Project: Accelerated dissociation of IgE-F&RI complexes by disruptive inhibitors actively desensitizes allergic effector cells (J Allergy Clin Immunol. 2014 Jun; 133(6): 1709-1719)
2014
Natalija Novak, MD
University of Bonn, Germany
Project: Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2 (Allergy Clin Immunol. 2012 Nov;130(5):1153-1158)
2013
Dr Christian Moebs
Philipps University, Marburg, Germany
Project: Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies (J Allergy Clin Immunol 2012;130:1108-16)
2012
Oscar Palomares Gracia, PhD
School of chemistry Ciuadad Universitaria s/n, Madrid, Spain
Project: Induction and maintenance of allergen-specific FOXp3+ Treg cells in human tonsils as potential first-line organs of oral tolerance (J Allergy Clin Immunol. 2011; 10.1016/2011.09.031)
2011
Denis Bedoret, DVM, PhD
Children's Hospital Boston, Boston, USA
Project: Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice (J. Clin. Invest. 2009: 119:3723–3738)
2010
Dr Jorge Esparza-Cordillo - MDC for Molecular Medicine, Berlin, Germany
Stephan Weidinger, MD - Technische Universität München, Munich, Germany
Project: A common variant on chromosome 11q13 is associated with atopic dermatitis
(Nature Genetics 2009;41:596-601)
2009
Dr Marco Idzko
COPD & Asthma Research-Group, University Hospital Freiburg, Freiburg, Germany
Project: Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells (Nature Medicine, 2007;13/8:913-919)
2008
Dr Georgina Xanthou
Biomedical Research Foundation, Academy of Athens (BRFAA), Athens, Greece
Project: Ostepontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets (Nature Medicine 2007; 13/5:570-578)
2007
Dr Carsten B. Schmidt-Weber
Swiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland
Project: Molecular mechanisms underlying FOXP3 induction in human T cells (The Journal of Immunology, 2006;176:3593-3602)
2006
Dr Claudia Traidl-Hoffmann
TU Munich, Munich, Germany
Project: Pollen associated phytoprostanes inhibit dendritic cell interleukin-12 production and augument T helper type 2 cell polarization (JEM 2005;201/4:627-635)
2005
Univ.Doz. Dr Barbara Bohle
AKH, University of Vienna, Vienna, Austria
Project: A novel approach in specific allergy treatment: The recombinant fusion protein of a bacterial cell surface (S-Layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity (The Journal of Immunology 2004;172:6642-48)
and
Dr Hamida Hammad
Erasmus Medical Centre, Rotterdam, The Netherlands
Project: Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen (J. Exp. Med. 2004;200:89-98)
2004
Prof Eckard H. Hamelmann, MD
Humboldt-University Berlin, Berlin, Germany
Project: Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice (J. Allergy Clin. Immunol. 2003;112:389-396)
and
Dr Eleanor Ling
Imperial College Faculty of Medicine, London, UK
Project: CD4+CD25+ regulatory T cell suppression of allergen-driven T cell activation is related to atopic status and expression of allergic disease (The Lancet 2004;363/9409:608-615)
2003
Dr Peter W. Hellings
University Hospital Gasthuisberg, Leuven, Belgium
Project: Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice (Eur. J. Immunol 2002;32:585-594)
2002
Dr Susanne Vrtala, AKH
University of Vienna, Vienna, Austria
Project: Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1 (FASEB J. 2001;15:2045-2047)
2001
Prof Cezmi A. Akdis, MD
Swiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland
Project: A molecular basis for T cell suppression by IL-10: CD28- associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding (FASEB J. 2000;14:1666-1668)
